Literature DB >> 170200

Immunization against experimental Chagas' disease by using culture forms of Trypanosoma cruzi killed with a solution of sodium perchlorate.

F Kierszenbaum, D B Budzko.   

Abstract

Protection against infection with virulent blood (trypomastigote) forms of Trypanosoma cruzi was accomplished in mice by immunization with culture (mainly epimastigote) forms killed by treatment with sodium perchlorate. Sodium chloride, used instead of sodium perchlorate, with all other conditions kept the same, failed to kill all the organisms, indicating that the effects of the perchlorate anion were not simply ionic or osmotic, suggesting that they might be chaotropic. A single dose of the immunogen, without adjuvants, was sufficient to significantly protect against the infection. Protection was achieved by either intraperitoneal, intramuscular, or subcutaneous immunization, though the first two routes appeared to be more effective. After challenge, parasitemias were negative in 25, 29, and 17% of the animals immunized intraperitoneally, intramuscularly, and subcutaneously, respectively.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170200      PMCID: PMC415308          DOI: 10.1128/iai.12.3.461-465.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  PROTECTIVE EFFECT OF KILLED TRYPANOSOME VACCINES WITH INCORPORATED ADJUVANTS.

Authors:  P JOHNSON; R A NEAL; D GALL
Journal:  Nature       Date:  1963-10-05       Impact factor: 49.962

2.  Immunological relationship between seven strains of Trypanosoma cruzi and its application in the diagnosis of Chagas' disease.

Authors:  T S HAUSCHKA; M B GOODWIN
Journal:  Am J Trop Med Hyg       Date:  1950-01       Impact factor: 2.345

3.  Some effects of gamma-radiation on Trypanosoma cruzi, culture and blood forms.

Authors:  E Chiari; E Mansur Neto; Z Brener
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1968 May-Jun       Impact factor: 1.846

4.  Complement-fixation tests, skin tests, and experimental immunization with antigens of Trypanosoma cruzi prepared under pressure.

Authors:  S M González Cappa; G A Schmuñis; O C Traversa; J F Yanovsky; A S Parodi
Journal:  Am J Trop Med Hyg       Date:  1968-09       Impact factor: 2.345

5.  Solubilization of particulate proteins and nonelectrolytes by chaotropic agents.

Authors:  Y Hatefi; W G Hanstein
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

Review 6.  Biology of Trypanosoma cruzi.

Authors:  Z Brener
Journal:  Annu Rev Microbiol       Date:  1973       Impact factor: 15.500

7.  The effects of bacterial endotoxin on the infection of mice with Trypanosoma cruzi.

Authors:  F Kierszenbaum; L E Saavedra
Journal:  J Protozool       Date:  1972-11

8.  The effect of chaotropic ions on the dissociation of antigen-antibody complexes.

Authors:  W B Dandliker; R Alonso; V A de Saussure; F Kierszenbaum; S A Levison; H C Schapiro
Journal:  Biochemistry       Date:  1967-05       Impact factor: 3.162

  8 in total
  5 in total

1.  Trypanosoma cruzi: properties of a clone isolated from CL strain.

Authors:  M T Lima; A M Jansen; E Rondinelli; C R Gattass
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

2.  Immunity against infection with Trypanosoma cruzi in mice correlates with presence of antibodies against three trypomastigote polypeptides.

Authors:  H J Zweerink; H D Weston; O F Andersen; S S Garber; E C Hayes
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

3.  Adoptive transfer of resistance to acute Trypanosoma cruzi infection with T-lymphocyte-enriched spleen cells.

Authors:  S G Reed
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

4.  Thymus-dependent control of host defense mechanisms against Trypanosoma cruzi infection.

Authors:  F Kierszenbaum; M M Pienkowski
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

5.  Mitomycin C-treated Trypanosoma cruzi in vaccination of mice: induction of immunosuppression but not protection.

Authors:  R L Tarleton; R E Kuhn; D S Cunningham
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.